Answer:
1/60 sq in
Explanation:
Use the triangle area formula.
bh
*
*
= 
Neither of those were developed to prevent global warming,in both cases that turned out to be one of the many potential positive results if the technology were widely accepted and implemented
The statement that is likely to occur in the future is new ethnicities will be formed, and old ethnicities will merge into one. The correct option is b.
<h3>What is ethnicity?</h3>
Ethnicity refers to a group's cultural identity, which is generally based on shared ancestry, language, and cultural traditions, whereas race refers to a taxonomic grouping based on physical similarities among groups.
The idea of race refers to the division of humans into groups based on diverse sets of physical features, as well as the process of assigning social significance to those categories.
Ethnicity describes a people's culture in a certain geographic area, encompassing their language, background, religion, and customs.
Therefore, the correct option is b, New ethnicities will be formed, and old ethnicities will merge into one.
To learn more about ethnicity, refer to the link:
brainly.com/question/12084761
#SPJ1
Answer:
In this study, we tested the effects of NEAA-deprived diets and checkpoint inhibitor anti-PD-1 and anti-PD-L1 in colon cancer using syngeneic mouse model (Balb/c) bearing tumors of mouse colorectal cancer cell line CT-26. Three diets were tested, including a natural rodent diet Teklad ENVIGO Global 16% Protein Rodent Diet (control 1), a formulated NEAA-complete diet COMPLETE (control 2, using amino acid mix in place of protein), and a formulated NEAA-deprived diet FTN203 (treatment, using amino acid mix in place of protein). Both COMPLETE and FTN203 have the same nutritional structures, contain 17% w/w protein equivalent, and are isocaloric. After tumor size-based randomization, these diets were provided to mice ad libitum throughout the whole test. Each of these diets was used alone or combined with anti-PD-1 antibody (i.p., twice per week for 2 weeks) or anti-PD-L1 antibody (i.v., twice per week for 2 weeks).
Explanation: